Trilogy Capital’s CDK Global, Inc. CDK Stock Holding History

Trilogy Capital’s Portfolio CDK Stock Details CDK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-21	Closed	-$1K	–	611
2018 Q3	$1K	Hold	21	–	–	﹤0.01%	604
2018 Q2	$1K	Hold	21	–	–	﹤0.01%	564
2018 Q1	$1K	Buy	+21	New	+$1.47K	﹤0.01%	470

Other funds holding CDK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Trilogy Capital's CDK Position: Q4 2018 in Review

Trilogy Capital sold out of CDK Global, Inc. (CDK) in Q4 2018, closing a stake of 21 shares — an estimated $1K sold.

Trilogy Capital first reported a position in CDK in Q1 2018 and held it in 3 quarters. The position peaked at $1K in Q3 2018. 572 funds tracked by Wall St. Rank hold CDK as of Q4 2018.

Trilogy Capital reported no remaining CDK Global, Inc. position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 21 CDK Global, Inc. shares in Q4 2018, an estimated $1K.
Trilogy Capital first reported a position in CDK Global, Inc. in Q1 2018 and held it in 3 quarters.
Trilogy Capital's CDK Global, Inc. position peaked at $1K in Q3 2018.
572 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.